William P. Quinn
Net Worth

Last updated:

What is William P. Quinn net worth?

The estimated net worth of Mr. William P. Quinn is at least $1,994,679 as of 12 Dec 2023. He owns shares worth $175,919 as insider and has received compensation worth at least $1,818,760 in Bolt Biotherapeutics, Inc..

What is the salary of William P. Quinn?

Mr. William P. Quinn salary is $454,690 per year as Chief Financial Officer in Bolt Biotherapeutics, Inc..

How old is William P. Quinn?

Mr. William P. Quinn is 54 years old, born in 1971.

What stocks does William P. Quinn currently own?

As insider, Mr. William P. Quinn owns shares in one company:

Company Title Shares Price per share Total value
Bolt Biotherapeutics, Inc. (BOLT) Chief Financial Officer 36,272 $4.85 $175,919

What does Bolt Biotherapeutics, Inc. do?

Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors; BDC-2034, a carcinoembryonic antigen program for colorectal, non-small cell lung, pancreatic, and breast cancers; and BDC-3042, a Dectin-2 agonist antibody program developed to repolarize critical cells in the tumor microenvironment by targeting cell-surface receptors on macrophages. It is also developing programmed cell death-ligand 1 program for tumors that are nonresponsive to immune checkpoint blockade. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood city, California.

BOLT logo
BOLT
Bolt Biotherapeutics, Inc.
$4.85

William P. Quinn insider trading

Bolt Biotherapeutics, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 7,500 $0.95 $7,125
Purchase
Common Stock 2,500 $0.78 $1,955
Purchase
Common Stock 5,000 $4.72 $23,575
Purchase
Common Stock 35 $4.64 $162
Purchase
Common Stock 1,221 $16.65 $20,330
Purchase
Common Stock 1,200 $20 $24,000

Bolt Biotherapeutics key executives

Bolt Biotherapeutics, Inc. executives and other stock owners filed with the SEC: